NPR1 Antibody

Polyclonal Antibody

NPR1

ANP-A antibody, ANPa antibody, ANPR-A antibody, ANPRA antibody, ANPRA_HUMAN antibody, Atrial natriuretic peptide A type receptor antibody, Atrial natriuretic peptide receptor 1 antibody, Atrial natriuretic peptide receptor A antibody, Atrial natriuretic peptide receptor type A antibody, Atrionatriuretic peptide receptor A antibody, GC A antibody, GC-A antibody, Guanylate cyclase A antibody, Guanylate cyclase antibody, GUC2A antibody, GUCY2A antibody, Natriuretic peptide A type receptor antibody, Natriuretic Peptide Receptor A antibody, Natriuretic peptide receptor A/guanylate cyclase A antibody, NPR-A antibody, NPR1 antibody, NPRA antibody

Synthetic peptide of human NPR1

Guanylyl cyclases, catalyzing the production of cGMP from GTP, are classified as soluble and membrane forms. The membrane guanylyl cyclases, often termed guanylyl cyclases A through F, form a family of cell-surface receptors with a similar topographic structure: an extracellular ligand-binding domain, a single membrane-spanning domain, and an intracellular region that contains a protein kinase-like domain and a cyclase catalytic domain. GC-A and GC-B function as receptors for natriuretic peptides, they are also referred to as atrial natriuretic peptide receptor A (NPR1) and type B (NPR2, MIM 108961). Also see NPR3 (MIM 108962), which encodes a protein with only the ligand-binding transmembrane and 37-amino acid cytoplasmic domains. NPR1 is a membrane-bound guanylate cyclase that serves as the receptor for both atrial and brain natriuretic peptides (ANP (MIM 108780) and BNP (MIM 600295), respectively).

Antigen Affinity Purified

Cardiovascular

Synthetic peptide of Human NPR1